









Longitudinal 18F-FDG PET imaging in a rat
model of autoimmune myocarditis
Rudolf A. Werner1,2,3,4, Hiroshi Wakabayashi2,4, Jochen Bauer5, Claudia Schütz6,
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Aims Although mortality rate is very high, diagnosis of acute myocarditis remains challenging with conventional tests. We
aimed to elucidate the potential role of longitudinal 2-Deoxy-2-18F-fluoro-D-glucose (18F-FDG) positron emission




Autoimmune myocarditis was induced in Lewis rats by immunizing with porcine cardiac myosin emulsified in com-
plete Freund’s adjuvant. Time course of disease was assessed by longitudinal 18F-FDG PET imaging. A correlative
analysis between in- and ex vivo 18F-FDG signalling and macrophage infiltration using CD68 staining was conducted.
Finally, immunohistochemistry analysis of the cell-adhesion markers CD34 and CD44 was performed at different
disease stages determined by longitudinal 18F-FDG PET imaging. After immunization, myocarditis rats revealed a
temporal increase in 18F-FDG uptake (peaked at week 3), which was followed by a rapid decline thereafter.
Localization of CD68 positive cells was well correlated with in vivo 18F-FDG PET signalling (R2 = 0.92) as well as
with ex vivo 18F-FDG autoradiography (R2 = 0.9, P < 0.001, respectively). CD44 positivity was primarily observed at
tissue samples obtained at acute phase (i.e. at peak 18F-FDG uptake), while CD34-positive staining areas were pre-
dominantly identified in samples harvested at both sub-acute and chronic phases (i.e. at 18F-FDG decrease).
...................................................................................................................................................................................................
Conclusion 18F-FDG PET imaging can provide non-invasive serial monitoring of cardiac inflammation in a rat model of acute
myocarditis.
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Introduction
Myocarditis is defined as myocardial infection in combination with
autoimmunity finally resulting in the inflammatory destruction of car-
diac myocytes.1 Silent myocarditis represents a major cause of unex-
pected deaths among children and is one of the main reasons of
sudden cardiac death in athletes under 35 years of age.2,3 To identify
high-risk patients eventually developing chronic dilated cardiomyop-
athy, disease activity should be closely monitored.4 Several
non-invasive imaging approaches have been advocated to provide
evidence of active myocardial inflammation and to differentiate be-
tween acute and post-inflammatory reaction, but none of the current
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methodology in place can solve this issue successfully4,5: For instance,
cardiac magnetic resonance imaging (cMRI) only allows for visualiza-
tion of indirect signs of myocardial inflammation, i.e. tissue oedema,
capillary leakage or necrosis indicated by late gadolinium enhance-
ment (LGE). Apart from that, the diagnostic accuracy of cMRI might
be hampered in challenging borderline cases.6
2-Deoxy-2-18F-fluoro-D-glucose (18F-FDG) positron emission
tomography (PET) has emerged as a tool for imaging of inflammatory
cardiovascular diseases such as myocardial infarction or athe-
rosclerosis.7 Activated leucocytes, especially macrophages, are
known to express high levels of glucose transporters, which result in
rapid accumulation of 18F-FDG at the site of inflammation.8,9 In the
present study, we aimed to elucidate the potential role of longitudinal
18F-FDG PET imaging in an experimental autoimmune myocarditis
rat model.
Methods
Animal protocols were approved by the local Animal Care and Use
Committee and conducted in accordance to the Guide for the Care and
Use of Laboratory Animals.10 Described reagents were commercially
available and used without further purification unless otherwise specified.
Rat model of experimental autoimmune
myocarditis
Female Lewis rats (Charles River Laboratories, 250–300 g) were immu-
nized with minor modifications based on a previously described
approach.11,12 In short, 0.5 mg/mL of antigen porcine cardiac myosin
(0.25 mL, Sigma Aldrich, St. Louis, MO, USA) was emulsified in an equal
volume of complete Freund’s adjuvant (Difco, Becton Dickinson,
Lawrence, KS, USA) supplemented with Mycobacterium tuberculosis
(Difco). On day 0 and day 7, this mixture was injected subcutaneously
(s.c.) into the rats’ back at three different sites13 and time zero was
defined as the time point of the second injection. Controls received saline
and Freund’s adjuvant alone (n = 4).
Study design
The first study was performed in a longitudinal setting to determine the
temporal cardiac 18F-FDG PET signal in a rat model of acute myocarditis.
Second, a correlative analysis between in vivo and ex vivo 18F-FDG results
and CD68 staining was performed. Finally, histological analysis of the ad-
hesion markers CD44 and CD34 at different inflammatory stages identi-
fied by serial 18F-FDG PET imaging was conducted. In total, 33 rats had
been investigated (longitudinal 18F-FDG PET imaging study, n = 8; correla-
tive analysis between 18F-FDG signal and CD68 histological staining,
n = 15; and cell surface marker immunohistochemistry for CD34 and
CD44, n = 10).
Longitudinal 18F-FDG PET imaging
A dedicated micro PET scanner (Inveon, Siemens Medical Solutions,
Erlangen, Germany) was used.14 To determine the time course and feasi-
bility of monitoring cardiac inflammation, serial 18F-FDG PET imaging (2,
3, 3.5, and 4 weeks after immunization) was performed in four myocardi-
tis rats. Animals underwent prior fasting over 14 h and bedding was
changed during the fasting period to avoid coprophagia or ingestion of
bedding. Rats received water ad libitum.15 One hour after intraperitoneal
(i.p.) administration of 37 MBq 18F-FDG, PET images were acquired over
7 min. Less than 5 min prior to PET acquisition, anaesthesia was started,
and all animals were maintained under anaesthesia throughout the
imaging procedure with 2% isoflurane. List-mode data were recon-
structed using ordered-subset expectation maximization with 16 subsets
and four iterations. Three-dimensional region of interests of the entire
heart were manually drawn using an imaging-processing application
(AMIDE-bin 1.0.2).16 The cardiac 18F-FDG uptake was visualized as the
percentage of the injected dose per tissue cubic centimetre (%ID/cm3)
and the distribution pattern [left ventricle (LV) vs. right ventricle (RV)]
was assessed visually over time. For the analysis of the regional most in-
tense uptake, the average value (%ID/cm3) of the five segments (anterior,
lateral, septal, inferior, and apex) was assessed. As a reference perfusion
marker, 18F-fluorobenzyl triphenyl phosphonium PET was conducted
subsequently (at acute phase of inflammation) and manual co-registration
to the 18F-FDG images was carefully performed.17 Moreover, myocardial
reference has also been obtained by a previously described protocol to
enhance tracer uptake in the myocardium.18
Correlative analysis between 18F-FDG signal
and CD68 histological staining
For autoradiography, 18F-FDG (37 MBq) was injected i.p. into myocarditis
rats after a 14 h fasting period. Guided by longitudinal 18F-FDG imaging,
myocardial tissue of nine rats was harvested at acute phase (i.e. at peak
18F-FDG uptake, 3 week post-immunization) and of six rats at subacute
phase (i.e. at decrease of 18F-FDG uptake, 5 week post-immunization).
Tracer distribution time was 60 min before euthanasia. Subsequently, the
heart was extracted, frozen and cut into 20-lm short-axis slices using a
cryostat (Leica, Nussloch, Germany). Immediately afterwards, the auto-
radiography plate (Multi Sensitive Phosphor Screens, PerkinElmer,
Shelton) was exposed to the slices for 60 min for visualization of 18F-FDG
distribution with a digital autoradiography system (CR 35 Bio, Raytest,
Packard, Straubenhardt, Germany).
Immunohistological CD68 analysis was performed using 7-lm slices
adjacent to the short-axis slices utilized for autoradiographic analysis.
Immunhistochemical staining with rabbit-anti CD68 (Abcam, Cambridge,
U.K.) antibodies was conducted as previously described.13 In short, after
fixation (acetone, 10 min) and blocking with 10% bovine serum albumin,
the incubation with CD68 antibodies was performed for 12 h. As a sec-
ondary antibody, biotinylated goat anti-rabbit IgG (Thermo Fisher
Scientific, Darmstadt, Germany) was used. Optical microscopy was per-
formed using a Keyence BZ-9000 microscope (Keyence Corporation,
Neu-Isenburg, Germany). Region of interests were set on the anterior,
lateral, inferior, and septal wall of the LV and on the RV on midventricular
short-axis slices. CD68 positivity in percentage was determined with
ImageJ software (version 1.47v, National Institutes of Health, Bethesda,
MD, USA) by using an intensity threshold that matched to the visually
identified staining areas as closely as possible.
Subsequently, for correlation of CD68-positive areas with in- and ex
vivo 18F-FDG uptake, region of interests were exclusively placed on areas
of increased cell infiltration of adjacent slides of CD68 staining, ex vivo
18F-FDG autoradiography and in vivo PET imaging.
Cell surface marker immunohistochemistry
for CD34 and CD44
Guided by longitudinal 18F-FDG imaging over time, the myocarditis rats
were assigned to three different stages for harvesting of myocardial tissue:
an acute phase at peak 18F-FDG uptake (3 week after immunization,
n = 4) as well as at subacute (5 week post-immunization, n = 3) and
chronic phases (10 week post-immunization, n = 3). The late phases were
both accompanied by decrease of tracer accumulation. To differentiate
between acute and post-inflammatory reaction, histological analysis at
each stage was conducted for the adhesion markers CD44 and CD34.
CD34 was shown to be expressed in vascular endothelial cells and

































































































endothelial progenitors.19 CD44 cells were also detected in vascular
adventitia20 and CD44 signalling was reported to be relevant in myocar-
dial infarction.21 Short-axis paraffin sections (5 lm thick) in 18F-FDG-avid
myocarditis were mounted on slides. Deparaffinization was achieved by
xylene immersion for 20 min and then followed consecutively by rehydra-
tion in 100%, 96%, 80%, and 70% ethanol. Deparaffinized slides were
blocked with 3% hydrogen peroxide, followed by heat-mediated antigen
retrieval by microwaving in 10 mM citrate buffer (pH, 6.0). Slides were
washed with phosphate-buffered saline and unspecific binding was
blocked with 5% normal goat serum, followed by separate immunostain-
ing with mouse anti-rat CD44 antibody and rabbit anti-mouse CD34 anti-
body (Thermo Fisher Scientific, Darmstadt, Germany). The following
secondary antibodies were used: goat anti-mouse IgG or anti-rabbit IgG
(Abcam, Cambridge, UK). A diaminobenzidine-H2O2 solution was uti-
lized to demonstrate peroxidase-conjugated secondary antibody binding.
Optical microscopy images were obtained by a Keyence BZ-9000 micro-
scope (Keyence Corporation, Neu-Isenburg, Germany). To quantify the
number of hematoxylin-, CD34-, and CD44-positive cells, the number of
stained cells was counted in a high-powered field (Image J, version 1.47v,
National Institutes of Health, Bethesda, MD, USA) by using an intensity
threshold that matched to the visually identified staining areas as closely
as possible.
Statistical analysis
All results are displayed as mean ± standard deviation. The two-tailed
paired Student’s t-test was used to compare differences between two de-
pendent groups, and the two-tailed independent Student’s t-test for dif-
ferences between independent groups. Multiple comparisons were
analysed by Dunn’s multiple comparison test and Tukey–Kramer test.
A P-value of less than 0.05 was assumed to be statistically significant.
Statistical analysis was done with StatMate III (ATMS Co., Ltd., Tokyo,
Japan). Linear regression test was performed for both CD68 and auto-
radiography analyses.
Results
Longitudinal 18F-FDG PET imaging
An averaged peak 18F-FDG uptake was noted 3 weeks after immun-
ization (%ID/cm3: 0.30 ± 0.09, 0.82 ± 0.27, at week 2, 3, respectively).
Of note, in a short-term follow-up at week 3.5 (day 25), a decline to
0.46± 0.19 could be observed, with a further decrease in week 4
(0.32± 0.10; week 2, 4 vs. 3, P < 0.05; respectively; Figure 1).
Reference perfusion marker demonstrated stability of tracer uptake
indicating no myocardial perfusion abnormalities. Compared to con-
trols (0.12 ± 0.01, 0.17 ± 0.02, at week 2, 3, respectively), a significant-
ly higher uptake for myocarditis rats could be observed at peak
uptake (controls vs. myocardits rats, P < 0.01, at week 2 and 3, re-
spectively). The uptake pattern in myocarditis rats over time was as
follows: At week 2, in 1/4 (25%), slight increased uptake in the RV
could be visualized. At peak of 18F-FDG uptake (week 3), both the
LV and RV were affected in all animals (LV þ RV, 4/4 (100%)). At
week 3.5, the following uptake distribution was noted: LV, 0/4 (0%);
RV, 1/4 (25%); LV þ RV, 2/4 (50%). At week 4, cardiac uptake could
not anymore visually assessed. At week 3, the most intense uptake
for every single of the four infected animals was located in the follow-
ing segments: anterior in two of the animals (%ID/cm3, 3.04, 1.81), lat-
eral in one animal (2.64) and anteroseptal (2.95) in another animal.
Correlative analysis between 18F-FDG
signal and CD68 histological staining
In- and ex vivo correlation of 18F-FDG uptake with immunohistochem-
ical findings were performed in cardiac sections stained with anti-
CD68 antibodies at acute phase (i.e. peak 18F-FDG uptake).
According to our immunostaining results, approximately 70% of the
cells in the inflammatory areas could be considered as macrophages.
An increase in 18F-FDG uptake was accompanied by an increase in
CD68 positivity at acute phase (week 3). The average values of 18F-
FDG uptake areas by in vivo PET were 0.05± 0.02% ID/g, for ex vivo
autoradiography 25.2 ± 13.1 mm2 and for CD68 staining 23.5 ± 7.4
mm2. On the contrary, the average values were decreased at sub-
acute phase at week 5 (in vivo PET, 0.001± 0.001% ID/g; ex vivo auto-
radiography, 1.2± 1.2 mm2, CD68 staining 0.6 ± 0.3 mm2).
A quantitative analysis demonstrated a good correlation between in
vivo 18F-FDG signal intensity as well as ex vivo autoradiographic studies
with CD68 positivity (CD68 positively stained areas with 18F-FDG
uptake by PET, R2 = 0.92 and with 18F-FDG autoradiography,
R2 = 0.9, P < 0.001, respectively; Figure 2).
Adhesion marker immunohistochemistry
CD34 and CD44
CD44 positive cells were observed in inflammatory lesions of the
acute phase and decreased time-dependently in both the subacute
and chronic phase. On the other hand, CD34 cells could not be iden-
tified in the acute phase (Figure 3A), while positively stained cells were
observed in the samples harvested at both subacute (Figure 3B) and
chronic phases (Figure 3C).
Quantification of haematoxylin and eosin staining revealed a de-
cline of haematoxylin positive cells over time (acute phase,
213.2± 172.3; subacute phase, 79.6 ± 43.1; chronic phase,
54.3 ± 33.8; acute vs. subacute phase and acute vs. chronic phase,
P < 0.05, respectively). Quantitative analysis of adhesion molecules
yielded a low CD34 positivity at acute phase in comparison to CD44
(2.5± 3.2% vs. 12.0± 6.2%, P < 0.001). At subacute phase, an increase
of CD34 positively stained cells and—conversely—a decrease of
CD44 positivity in the neovasculature of the injured area was
observed (12.0 ± 3.9% vs. 1.6± 2.1%, P < 0.001). The same tendency
was detected at chronic phase with a slight decrease for CD34,
whereas CD44 had almost vanished (7.4 ± 1.9% vs. 0.3± 0.4%,
P < 0.001). A quantitative analysis of both adhesion markers for all
three phases is displayed in Figure 3D.
Discussion
Reflected by current guidelines, endomyocardial biopsy is recom-
mended for substantially all patients in the life-threatening clinical
presentations, in particular as it is the only methodology that pro-
vides in vivo evidence to differentiate between active and post-
inflammatory myocarditis.22,23 The presence of LGE on cMRI seems
to be associated with histological proven active myocarditis, but it
might also remain present if acute inflammation has subsided and sub-
sequent scarring has occurred.4,24 However, the herein presented
exchange of adhesive molecules guided by longitudinal 18F-FDG
imaging enables to discriminate between acute vs. post-inflammatory
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Figure 1 Longitudinal 18F-FDG PET imaging. (A) Total 18F-FDG uptake by PET given at week 1, 2, 3, 3.5, and 4. Uptake peaked at week 3, whereas
a decrease could already be visualized at week 3.5. A good discrimination compared with controls could be observed. (B) In vivo PET imaging 3 weeks
after immunization (acute phase). Myocardial reference PET (18F-FDG under insulin stimulation, left), 18F-FDG PET (middle) and 3D volume render-
ing view (right). Clear focal 18F-FDG uptake signal in the heart can be observed (white dotted circles). (C) Serial 18F-FDG imaging 2, 3, and 4 weeks
after immunization with representative short-axis and horizontal long-axis PET images of a myocarditis rat. Inflammation indicated by 18F-FDG starts
at the right ventricle (week 2), whereas at week 3, the global heart is affected (red dotted circles). Grayscale images served as a myocardial reference.
EAM, experimental autoimmune myocarditis.










































.reaction: The adhesion transmembrane receptor CD44 is critically
involved in acute inflammation, as it promotes the recruitment of
macrophages.25,26 On the other hand, CD34 positive cells contribute
to post-inflammatory reaction.27,28
CD44 is expressed on both endothelial and inflammatory cells and
is known to play a key role for acute inflammatory response: it mod-
erates adhesion of T lymphocytes to the endothelium29 and releases
mediator components from macrophages.30 Yoshida et al.26 investi-
gated the same experimental autoimmune myocarditis model and
analogous to our findings, a time-dependent expression of CD44 in
the rat heart could be demonstrated: CD44 peaked 3 weeks after im-
munization, followed by a remarkable decline at chronic phase (12
weeks). However, CD44 in myocarditis is also prone to species-
specific variations: Abel et al.31 used a murine myocarditis model and
showed that CD44 seemed to be rather absent in the mice myocar-
dium. Hence, extrapolations for the inflammatory regulation of
CD44 from one species to another may have to be drawn with ex-
treme caution. Also adding to the complexity of targeting CD44, its
function might even vary among different tissues in the same species:
in contrast to the negligible role in the infected mice myocardium,31
CD44 was critically involved in a murine model of thyroid gland
inflammation.32 Nonetheless, analogous to our findings of CD34 con-
tribution to post-inflammatory reaction in myocarditis rats, an
increased cardiac CD34þ cell mobilization at chronic phase has been
recently demonstrated in a Coxsackie virus myocarditis model.28
However, depending on the used species, one might have to expect
different peaks of inflammatory response: contrary to our findings
with EAM rats, SWR/J mice infected with coxsackievirus B3 devel-
oped acute myocarditis 6–12 days post-injection.28
Apart from that, CD68 for the assessment of activated macro-
phages has been extensively used for endomyocardial biopsy in a clin-
ical setting.33 In our study, CD68 staining confirmed that
macrophages represented the majority of infiltrative cells at peak 18F-
FDG uptake. Although linear regression might have predominantly
been driven by animals with intense reaction to immunization
(Figure 2), correlative analysis with in- and ex vivo 18F-FDG signalling
demonstrated that the radiotracer accumulation matched well with
macrophage infiltration. Albeit this might not reflect the variance in
inflammation pattern and severity induced by myocarditis, even ex-
clusion of those two animals with intensive reaction still led to con-
siderably high R2 values of >_0.86. Hence, imaging with 18F-FDG could
improve the accuracy of endomyocardial biopsy by reducing the risk
Figure 2 Upper row: HE-, CD68-staining, and 18F-FDG autoradiography images of a myocarditis rat. Lower row: In vivo correlation of 18F-FDG
(%ID/g) by PET as well as ex vivo 18F-FDG uptake by autoradiography (mm2) with CD68 positive stained myocardial areas (mm2). Guided by
18F-FDG in vivo PET imaging, rats were selected at peak 18F-FDG uptake (3 weeks post-immunization, acute phase) and at time-point of 18F-FDG de-
crease thereafter (5 weeks post-immunization, subacute phase). A good correlation for in vivo 18F-FDG (R2 = 0.92) as well as for autoradiography find-
ings (R2 = 0.9) with CD68 positive areas was detected (P < 0.001, respectively). White dots indicate animals, in which myocardial tissue had been
harvested at week 3 (acute phase) and black dots indicate animals, in which cardiac tissue had been harvested at week 5 (subacute phase). Wk, week.






































of sampling errors. In addition to that, the potential of 18F-FDG for
PET-guided biopsies has been recently confirmed in patients with
clinically suspected active myocarditis.34
Analogous to the findings of the present study using PET, the area
of LGE obtained by cMRI matched with histologically proven myocar-
ditis at day 21 in Lewis rats.35 MRI sequences can monitor structural
alterations, i.e. tissue oedema, capillary leakage, or necrosis.4
However, functional imaging modalities offer several key advantages
in non-invasive inflammatory imaging, e.g. direct interrogation of infil-
trating immune cells on a subcellular level.7 Consequently, the com-
bination of PET and MRI could provide incremental information
about myocardial injury and inflammatory activity: in a small cohort
of ten patients, simultaneous PET/MRI using 18F-FDG was feasible to
diagnose both cardiac sarcoidosis and myocarditis.36 Thus, such an
imaging approach could also potentially be applied in the herein pre-
sented experimental setting.
An extensive body of evidence reported on the suitability of
gamma emitting compounds to localize inflammatory sites in the
human heart.37,38 However, even promising candidates, such as
67Galllium citrate showed a lack of sensitivity in detecting myocardial
infiltration.37 To overcome limitations of conventional scintigraphy
studies, PET offers improved spatial and temporal resolution along
with the possibility of quantification approaches. By visualizing infiltra-
tion of mannose receptor-positive macrophages, Lee et al.39 have
recently introduced the PET compound 68Ga-2-(p-isothiocyanato-
benzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid mannosylated
human serum albumin (68Ga-NOTA-MSA): Compared with its novel
68Ga-labelled counterpart, the sensitivity of 18F-FDG to detect car-
diac inflammatory cell infiltration was reduced. However, an 18F-
labelled PET imaging agent such as FDG inherits all advantages of 18F-
radionuclides, i.e. lower positron energy along with higher positron
yield, logistical benefits (longer physical half-life), cost-effectiveness
(use of deliveraging system), availability at almost every PET centre,
as well as the potential of delayed imaging protocols.40,41 In addition,
glucose can be seen as the backbone of monitoring inflammatory
processes, as neutrophils up-regulate GLUT1/3 transporters as well
Figure 3 Exchange of adhesion molecules CD34 and CD44, guided by longitudinal in vivo PET imaging. (A) At acute phase (3 weeks after immuniza-
tion), a peak 18F-FDG uptake was recorded, with corresponding CD44 positive stained myocardial areas. (B) At subacute phase (5 weeks post-im-
munization) and (C) chronic phase (10 weeks post-immunization), PET revealed a decline of cardiac tracer uptake: An increase in CD34 positivity
was noted, whereas a further decrease of CD44 positively stained cells could be identified. (D) Quantitative analysis of adhesion markers at different
phases revealed a low CD34 and—conversely—an increased CD44 positivity (in %) at acute phase. At both subacute and chronic phases, opposite
findings with CD34 positively stained areas and a further decrease in CD44 positivity were recorded.

































































































as hexokinase activity.42 Furthermore, a good correlation between
macrophage infiltration and 18F-FDG signalling was demonstrated in
the present study. Recently, the potential of the novel PET probe
11C-methionine for the assessment of myocardial infiltration in the
same autoimmune myocarditis rat model had been investigated:
Apart from the longer half-life of 18F-labelled (110 min) compared to
carbon-11 tracers (20.4 min), 18F-FDG demonstrated a lower uptake
in both the liver and the thymus.13 However, inflammatory PET imag-
ing with 18F-FDG suffers from several limitations: first, physiological
18F-FDG uptake in the heart has to be suppressed and common clin-
ical protocols might not work equally for healthy and impaired
myocardium.7 To address these issues, rats were placed on pro-
longed fasting. Additionally, unnecessary narcosis procedures, which
might mask the efficacy of glucose suppression,43 were abandoned in
our study (i.p. instead of i.v. tracer injection). However, plasma glu-
cose levels cannot be provided, but previous studies have already
reported that conscious (i.p.) injection of 18F-FDG in rodents signifi-
cantly reduces cardiac uptake, which can be further suppressed by
fasting.43 Hence, given these drawbacks of 18F-FDG, other more
leukocyte-specific tracers (e.g. 68Ga-Pentixafor or 18F-GE180), might
be subject of future studies for investigating the inflammatory cascade
in myocarditis.7 Moreover, the small sample size in the CD34/CD44
assessment of the present study limits its statistical power. Thus, the
herein presented findings should rather be interpreted with caution
and as a ‘proof-of-concept’ and re-examinations with a larger number
of animals could strengthen our preliminary findings. As CD44 can
also lead to an adhesion of activated T-lymphocytes to the
endothelium,29 a further assessment of T-lymphocyte activation and
infiltration might pave the way for a deeper understanding between
18F-FDG uptake and inflammatory response. Moreover, 18F-FDG
PET has been used to monitor response to prednisolone in a small
patient cohort suffering from arteritis.44 Hence, the herein presented
experimental setting could also be used to investigate if 18F-FDG
might be suitable to identify responders to immunosuppressive ther-
apy in myocarditis.
Conclusions
In an experimental autoimmune myocarditis rat model, longitudinal
18F-FDG PET imaging demonstrated favourable properties to differ-
entiate between active from post-inflammatory reaction.
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